ENAapplication/xmlftp://ftp.sra.ebi.ac.uk/vol1/fastq/SRR185/096/SRR18572996/SRR18572996.fastq.gzftp://ftp.sra.ebi.ac.uk/vol1/fastq/SRR185/000/SRR18573000/SRR18573000.fastq.gzftp://ftp.sra.ebi.ac.uk/vol1/fastq/SRR185/097/SRR18572997/SRR18572997.fastq.gzftp://ftp.sra.ebi.ac.uk/vol1/fastq/SRR185/095/SRR18572995/SRR18572995.fastq.gzftp://ftp.sra.ebi.ac.uk/vol1/fastq/SRR185/098/SRR18572998/SRR18572998.fastq.gzftp://ftp.sra.ebi.ac.uk/vol1/fastq/SRR185/099/SRR18572999/SRR18572999.fastq.gzprimaryOK200GenomicsBiological Information, Weizmann Institute of Sciencehttps://www.ebi.ac.uk/ena/browser/view/PRJNA822422Homo sapiensWe identified two epigenetically distinct subpopulations in DIGP, reflecting inherent heterogeneity in the expression levels of the mutant histone. Overall design: Examination of different cell lines expressing the H3-K27M mutant histoneENAGlioma NOS, cytoplasmic chromatin, d230, determination, glial tumors, dTAFII250, Mixed Glioma, His-3.3A, Neuroglial Tumor, Tumor, EfW1, Malignant, dmTAF[[II]]230, [M]Glioma NOS (morphologic abnormality), dmTAF1, Taf230, [M]Gliomas (morphologic abnormality), PH3, Mixed Gliomas, Chromatins, TAF250, h3.3a, Taf200, dTAF[[II]]250, TFIID TAF250, glioma (morphologic abnormality), Glioma NOS (morphologic abnormality), cel, cell, Neoplasm of the Neuroglia, Taf1p, Glial Neoplasm, H3.3B, Epigenomic, His3.3, H3.3A, HisH3-3Q, dTAF250, DmelCG5825, Neoplasms of Neuroglia., chromosome scaffold, CG8989, Gliomas (morphologic abnormality), [M]Gliomas, TAF, Tumors of Neuroglia, anon-EST:fe1B6, Tumors, nuclear chromatin, Glioma (except Nasal glioma, dTAF[[II]]230, TAF[[II]]250, malignant, TAF200, l(3)84Ab, obsolete_glioma, Malignant Glioma, BG:DS00004.13, TAFII-250, TAF250/230, Cell, dTAF230, TAFII250, p230, chemical analysis, TAF[[II]]250/230, TFIID, Gliomas, Mixed, Glial Cell Tumor, [M]Glioma NOS, Taf[[II]]250, Glial Tumor, DmelCG8989, NOS (except Nasal glioma, TAF[[II]]230, Neuroglial Neoplasm, Neuroglial Neoplasms, Epigenetic, Glial Cell, H3.3, Malignant glioma, TAF[II]250, Tumor of Neuroglia, CG17603, TAF[[II]], CG5825, dH3.3B, dH3.3A, h3.3, Neoplasm of Neuroglia, DmelCG17603, no ICD-O subtype, Taf250, SR3-5, Tumor of the Neuroglia, Glial Cell Tumors, not neoplastic), Malignant Gliomas, Glioma, assay, Epigenetics, malignant (morphologic abnormality), TAF230, TAF1Glioma NOS, cytoplasmic chromatin, d230, determination, glial tumors, dTAFII250, Mixed Glioma, His-3.3A, Neuroglial Tumor, Tumor, EfW1, Malignant, dmTAF[[II]]230, [M]Glioma NOS (morphologic abnormality), dmTAF1, Taf230, [M]Gliomas (morphologic abnormality), PH3, Mixed Gliomas, Chromatins, TAF250, h3.3a, Taf200, dTAF[[II]]250, TFIID TAF250, glioma (morphologic abnormality), Glioma NOS (morphologic abnormality), cel, cell, Neoplasm of the Neuroglia, Taf1p, Glial Neoplasm, H3.3B, Epigenomic, His3.3, H3.3A, HisH3-3Q, dTAF250, DmelCG5825, Neoplasms of Neuroglia., chromosome scaffold, CG8989, Gliomas (morphologic abnormality), [M]Gliomas, TAF, Tumors of Neuroglia, anon-EST:fe1B6, Tumors, nuclear chromatin, Glioma (except Nasal glioma, dTAF[[II]]230, TAF[[II]]250, malignant, TAF200, l(3)84Ab, obsolete_glioma, Malignant Glioma, BG:DS00004.13, TAFII-250, TAF250/230, Cell, dTAF230, TAFII250, p230, chemical analysis, TAF[[II]]250/230, TFIID, Gliomas, Mixed, Glial Cell Tumor, [M]Glioma NOS, Taf[[II]]250, Glial Tumor, DmelCG8989, NOS (except Nasal glioma, TAF[[II]]230, Neuroglial Neoplasm, Neuroglial Neoplasms, Epigenetic, Glial Cell, H3.3, Malignant glioma, TAF[II]250, Tumor of Neuroglia, CG17603, TAF[[II]], CG5825, dH3.3B, dH3.3A, h3.3, Neoplasm of Neuroglia, DmelCG17603, no ICD-O subtype, Taf250, SR3-5, Tumor of the Neuroglia, Glial Cell Tumors, not neoplastic), Malignant Gliomas, Glioma, assay, Epigenetics, malignant (morphologic abnormality), TAF230, TAF1falseSingle-cell epigenetic analysis reveals principles of chromatin states in H3.3-K27M gliomasSingle-cell epigenetic analysis reveals principles of chromatin states in H3.3-K27M gliomas2025-09-242022-06-12PRJNA822422GSE2000019606